FI964537A - Menetelmiä peroksinitriitin hajoamiskatalyyttien käyttämiseksi, farmaseuttisia koostumuksia sitä varten - Google Patents
Menetelmiä peroksinitriitin hajoamiskatalyyttien käyttämiseksi, farmaseuttisia koostumuksia sitä varten Download PDFInfo
- Publication number
- FI964537A FI964537A FI964537A FI964537A FI964537A FI 964537 A FI964537 A FI 964537A FI 964537 A FI964537 A FI 964537A FI 964537 A FI964537 A FI 964537A FI 964537 A FI964537 A FI 964537A
- Authority
- FI
- Finland
- Prior art keywords
- peroxynitrite
- pharmaceutical compositions
- methods
- same
- decomposition catalysts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24249894A | 1994-05-13 | 1994-05-13 | |
PCT/US1995/005886 WO1995031197A1 (en) | 1994-05-13 | 1995-05-09 | Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
FI964537A0 FI964537A0 (fi) | 1996-11-12 |
FI964537A true FI964537A (fi) | 1997-01-10 |
Family
ID=22915009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI964537A FI964537A (fi) | 1994-05-13 | 1996-11-12 | Menetelmiä peroksinitriitin hajoamiskatalyyttien käyttämiseksi, farmaseuttisia koostumuksia sitä varten |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0758892A1 (zh) |
JP (1) | JPH10500671A (zh) |
CN (1) | CN1222286C (zh) |
AU (1) | AU709553B2 (zh) |
BR (1) | BR9507643A (zh) |
CA (1) | CA2189528A1 (zh) |
CZ (1) | CZ323496A3 (zh) |
FI (1) | FI964537A (zh) |
HU (1) | HUT76327A (zh) |
NO (1) | NO964793L (zh) |
NZ (1) | NZ285648A (zh) |
PL (1) | PL317192A1 (zh) |
WO (1) | WO1995031197A1 (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6127356A (en) | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
US5994339A (en) * | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
AU3758695A (en) * | 1994-09-20 | 1996-04-09 | Duke University | Oxidoreductase activity of manganic porphyrins |
DE69813898T2 (de) | 1997-11-03 | 2004-03-11 | Duke University | Substituierte porphyrinen |
AU771259B2 (en) | 1998-04-24 | 2004-03-18 | Aeolus Sciences, Inc. | Substituted porphyrins |
WO2000009111A2 (en) * | 1998-08-11 | 2000-02-24 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Inhibitors of amyloid formation |
IL126953A0 (en) * | 1998-11-08 | 1999-09-22 | Yeda Res & Dev | Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives |
EP1013272A1 (en) * | 1998-12-23 | 2000-06-28 | Biomedical Primate Research Centre (BPRC) | Manipulation of the activity of a nitric oxide radical production pathway for the treatment of diseases associated with the presence of oxygen free radicals |
MXPA01007451A (es) | 1999-01-25 | 2004-03-10 | Nat Jewish Med & Res Center | Porfirinas sustituidas. |
US6448239B1 (en) | 1999-06-03 | 2002-09-10 | Trustees Of Princeton University | Peroxynitrite decomposition catalysts and methods of use thereof |
FR2806911B1 (fr) * | 2000-03-28 | 2003-01-10 | Univ Rene Descartes | Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires |
ATE439134T1 (de) * | 2001-01-19 | 2009-08-15 | Nat Jewish Med & Res Center | Medikament zum schutz in der radiotherapie |
WO2002098431A1 (en) | 2001-06-01 | 2002-12-12 | National Jewish Medical And Research Center | Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
CA2488500A1 (en) | 2002-06-07 | 2003-12-18 | Duke University | Substituted porphyrins |
DE10240343A1 (de) * | 2002-08-27 | 2004-03-11 | Schering Ag | Peroxynitrit-Umlagerungskatalysatoren |
US6946466B2 (en) * | 2003-04-10 | 2005-09-20 | Schering Ag | Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
US8165651B2 (en) | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
US7699964B2 (en) | 2004-02-09 | 2010-04-20 | Abbott Diabetes Care Inc. | Membrane suitable for use in an analyte sensor, analyte sensor, and associated method |
US7705040B2 (en) * | 2005-10-07 | 2010-04-27 | The University Of Hong Kong | Reagents for highly specific detection of peroxynitrite |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US8232267B2 (en) | 2006-10-06 | 2012-07-31 | The Trustees Of Princeton University | Porphyrin catalysts and methods of use thereof |
CA2698552C (en) * | 2007-08-28 | 2014-10-28 | Technion Research And Development Foundation Ltd. | Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
RU2506083C2 (ru) | 2008-05-23 | 2014-02-10 | Нэшнл Джуиш Хелт | Способ лечения поражений, ассоциированных с воздействием алкилирующих веществ |
CN105899132B (zh) | 2013-12-31 | 2020-02-18 | 雅培糖尿病护理公司 | 自供电分析物传感器以及使用其的装置 |
RU2557655C1 (ru) * | 2014-06-10 | 2015-07-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановский государственный химико-технологический университет" (ФГБОУ ВПО "ИГХТУ") | Никелевый комплекс 5,10,15,20-тетракис[3',5'-ди(2"-метилбутилокси)фенил]-порфина, проявляющий свойство стационарной фазы для газовой хроматографии |
CN107573259A (zh) * | 2017-09-25 | 2018-01-12 | 沅江华龙催化科技有限公司 | 一种金属卟啉催化芳香烯烃合成芳香腈的方法 |
EP4059496A1 (en) * | 2021-03-18 | 2022-09-21 | Institut Pasteur | Mntbap and m(iii) n-substituted pyridylporphyrins (mnps) for use in reversing sepsis-induced microglial cells alteration(s), associated long-term cognitive impairment, and/or for treating sepsis or sepsis-associated encephalopathy (sae), and/or related short and/or long-term symptoms or complications thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0210351B1 (en) * | 1985-04-30 | 1993-07-21 | Nippon Petrochemicals Co., Ltd. | Use of porphyrin derivatives in the detection and treatment of tumours |
CA1340951C (en) * | 1986-01-02 | 2000-04-11 | Alan R. Moragn | Production and use of purpurins, chlorins and purpurin-and chlorin-containing compositions |
US4866054A (en) * | 1986-05-13 | 1989-09-12 | Chai-Tech Corporation | Antioxidant metallo-organic treatment of inflammation |
WO1989002269A1 (en) * | 1987-09-08 | 1989-03-23 | The Rockefeller University | Use of metalloporphyrins to reverse the toxic effect of tumor therapy |
ES2094795T3 (es) * | 1990-11-02 | 1997-02-01 | Ici Plc | Ftalocianinas polisustituidas. |
WO1992008482A1 (en) * | 1990-11-14 | 1992-05-29 | Uab Research Foundation | Compositions for reducing oxidative injury |
FR2676738B1 (fr) * | 1991-05-22 | 1995-05-05 | Ir2M | Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante. |
GB9111689D0 (en) * | 1991-05-31 | 1991-07-24 | Johnson Matthey Plc | Gallium compounds |
WO1993002090A1 (en) * | 1991-07-19 | 1993-02-04 | Monsanto Company | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
CA2124204A1 (en) * | 1991-11-25 | 1993-06-10 | H. Dewayne Ashmead | Composition and method for reducing free radical cellular oxidative stress in warm-blooded animals |
US5296466A (en) * | 1992-02-19 | 1994-03-22 | Board Of Regents, The University Of Texas System | Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US6204259B1 (en) * | 1993-01-14 | 2001-03-20 | Monsanto Company | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
GB9309387D0 (en) * | 1993-05-06 | 1993-06-16 | Wellcome Found | Nitric oxide scavengers |
GB9317686D0 (en) * | 1993-08-25 | 1993-10-13 | Johnson Matthey Plc | Pharmaceutical compositions |
-
1995
- 1995-05-09 JP JP7529755A patent/JPH10500671A/ja not_active Ceased
- 1995-05-09 HU HU9603140A patent/HUT76327A/hu not_active Application Discontinuation
- 1995-05-09 AU AU25120/95A patent/AU709553B2/en not_active Ceased
- 1995-05-09 CZ CZ963234A patent/CZ323496A3/cs unknown
- 1995-05-09 CN CNB951940759A patent/CN1222286C/zh not_active Expired - Fee Related
- 1995-05-09 BR BR9507643A patent/BR9507643A/pt not_active Application Discontinuation
- 1995-05-09 WO PCT/US1995/005886 patent/WO1995031197A1/en not_active Application Discontinuation
- 1995-05-09 PL PL95317192A patent/PL317192A1/xx unknown
- 1995-05-09 NZ NZ285648A patent/NZ285648A/xx unknown
- 1995-05-09 CA CA002189528A patent/CA2189528A1/en not_active Abandoned
- 1995-05-09 EP EP95919143A patent/EP0758892A1/en not_active Withdrawn
-
1996
- 1996-11-12 FI FI964537A patent/FI964537A/fi not_active IP Right Cessation
- 1996-11-12 NO NO964793A patent/NO964793L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUT76327A (en) | 1997-08-28 |
WO1995031197A1 (en) | 1995-11-23 |
AU709553B2 (en) | 1999-09-02 |
EP0758892A1 (en) | 1997-02-26 |
JPH10500671A (ja) | 1998-01-20 |
FI964537A0 (fi) | 1996-11-12 |
BR9507643A (pt) | 1997-09-23 |
CA2189528A1 (en) | 1995-11-23 |
PL317192A1 (en) | 1997-03-17 |
CN1152871A (zh) | 1997-06-25 |
HU9603140D0 (en) | 1997-01-28 |
CN1222286C (zh) | 2005-10-12 |
NO964793D0 (no) | 1996-11-12 |
NO964793L (no) | 1997-01-06 |
AU2512095A (en) | 1995-12-05 |
CZ323496A3 (en) | 1997-10-15 |
NZ285648A (en) | 1999-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI964537A (fi) | Menetelmiä peroksinitriitin hajoamiskatalyyttien käyttämiseksi, farmaseuttisia koostumuksia sitä varten | |
DK0747050T4 (da) | Farmaceutiske sammensætninger, der indeholder irbesartan | |
HUP9900625A3 (en) | Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds | |
HUP0003309A3 (en) | Imidazolyl-cyclic acetals, process for producing them and pharmaceutical compositions containing the same | |
HUP9902455A3 (en) | 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them | |
HUP9603494A3 (en) | Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof | |
HUP0000941A3 (en) | Sulfamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
DE59507593D1 (de) | Gaserzeugendes, azidfreies Stoffgemisch | |
NO976121L (no) | FremgangsmÕte for fremstilling av karbonylforbindelser | |
NO983068D0 (no) | FremgangsmÕte for fremstilling av bis-syklopentadienyl-dien komplekser | |
NO904222L (no) | Fremgangsmaate for fremstilling av benzodiazepiner. | |
NO20000355D0 (no) | Fremgangsmåte for fremstilling av cyklopropylacetylen | |
FI973644A (fi) | Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi | |
NO941648D0 (no) | Fremgangsmåte for fremstilling av katalysatorer | |
FI956058A (fi) | Menetelmä glutaaridialdehydin valmistamiseksi | |
NO985535D0 (no) | FremgangsmÕte for fremstilling av 1,3-alkandioler | |
NO996432D0 (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
NO984905D0 (no) | FremgangsmÕte for fremstilling av b°rstevarer | |
FI101472B1 (fi) | Menetelmä 1,3-diolien monoesterien valmistamiseksi | |
DZ2302A1 (fr) | Produit pharmaceutique cristallin. | |
FI963466A0 (fi) | Menetelmä selluloosakarbamaatin valmistamiseksi | |
FI964829A (fi) | Menetelmä 2,2,4-trimetyyli-1,3-pentaanidioli-isobutyraatin valmistamiseksi | |
FI961178A (fi) | Menetelmä syklisten cis-1-amino-2-alkanolien valmistamiseksi | |
FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi | |
FI971964A0 (fi) | Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |